#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA752080	B	Percent of Monophosphate forms of compound at 24 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	2		single protein format	Scientific Literature
2.	ALA752081	B	Percent of diphosphate forms of compound at 2 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	2		single protein format	Scientific Literature
3.	ALA752085	B	Percent of Monophosphate forms of compound at 2 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	3		single protein format	Scientific Literature
4.	ALA752087	B	Percent of diphosphate forms of compound at 24 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	3		single protein format	Scientific Literature
5.	ALA752090	B	Percent of triphosphate forms of compound at 24 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	3		single protein format	Scientific Literature
6.	ALA752091	B	Percent of triphosphate forms of compound at 2 hr after phosphorylation by nucleoside monophosphate kinase	Bos taurus	3		single protein format	Scientific Literature
7.	ALA3282730	F	Antiviral activity against Herpesvirus 1 infected in human KB cells assessed as virus-induced cytopathic effect after 72 hrs	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature
8.	ALA3282731	F	Antiviral activity against Herpesvirus 2 infected in human KB cells assessed as virus-induced cytopathic effect after 72 hrs	Human alphaherpesvirus 2	4		organism-based format	Scientific Literature
9.	ALA3282732	F	Antiviral activity against Vaccinia virus infected in human KB cells assessed as virus-induced cytopathic effect after 72 hrs	Vaccinia virus	4		organism-based format	Scientific Literature
10.	ALA3282733	A	Cytotoxicity against human KB cells after 72 hrs	Homo sapiens	4		cell-based format	Scientific Literature
11.	ALA3282734	F	Antiviral activity against Herpesvirus 1 123 infected in Swiss mouse assessed as increase in survival at MTD, ic administered as single dose 6 hrs post infection relative to control	Human alphaherpesvirus 1	4		organism-based format	Scientific Literature